a progressive brain disorder that impacts memory, thinking and behaviour. As The Express reports, the new drug has been shown ...

A groundbreaking medication designed to delay the onset of Alzheimer's has received approval for use within the EU. The drug, ...

A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...

Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer ...

The U.S. Food and Drug Administration approved PTC Therapeutics, Inc.'s Kebilidi (eladocagene exuparvovec-tneq) gene therapy for the ...

In a small early trial using a transcranial magnetic stimulation procedure, scientists were able to target a key brain ...

This is the first gene therapy for AADC deficiency to receive US regulatory approval and the first that can be administered directly to the brain.

Telix is also reviewing the potential use of Pixclara as a "companion" diagnostic agent for TLX101-Tx, the investigational neuro-oncology drug ... approval of Pixclara will drive a step-change for ...

Thermo Fisher Scientific has announced that its in vitro diagnostic test, Oncomine, has won US Food and Drug Administration ... s Oncomine gains FDA approval as brain tumor diagnostic" was ...